Literature DB >> 2937016

Base substitution mutations induced in the cI gene of lambda phage by neocarzinostatin chromophore: correlation with depyrimidination hotspots at the sequence AGC.

L F Povirk, I H Goldberg.   

Abstract

Treatment of intact lambda phage with the nonprotein chromophore of neocarzinostatin resulted in efficient phage inactivation and generation of clear-plaque mutants. Both effects required a preincubation at low pH to allow diffusion of chromophore into the phage head. Chromophore activation was then effected by addition of a sulfhydryl cofactor, followed by a shift to neutral pH. Sequence analysis of mutations mapped to the DNA-binding region of the cI gene revealed that nearly all were single base substitutions. Significant numbers of all possible base changes were found, with A:T to G:C transitions being the most frequent events. Of 11 G:C to A:T transitions, 7 were found at C residues in the trinucleotide sequence AGC, which has previously been shown to be a hotspot for chromophore-induced depyrimidination. This result, as well as the SOS dependence of mutagenesis and the overall distribution of various types of base substitutions, is consistent with the hypothesis that apurinic/apyrimidinic sites are important mutagenic lesions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937016      PMCID: PMC339514          DOI: 10.1093/nar/14.3.1417

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  NEOCARZINOSTATIN, AN ANTITUMOR ANTIBIOTIC OF HIGH MOLECULAR WEIGHT. ISOLATION, PHYSIOCHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.

Authors:  N ISHIDA; K MIYAZAKI; K KUMAGAI; M RIKIMARU
Journal:  J Antibiot (Tokyo)       Date:  1965-03       Impact factor: 2.649

2.  Nucleotide specificity in DNA scission by neocarzinostatin.

Authors:  T Hatayama; I H Goldberg; M Takeshita; A P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Detection of neocarzinostatin chromophore-deoxyribose adducts as exonuclease-resistant sites in defined-sequence DNA.

Authors:  L F Povirk; I H Goldberg
Journal:  Biochemistry       Date:  1985-07-16       Impact factor: 3.162

4.  DNA base sequence changes induced by bromouracil mutagenesis of lambda phage.

Authors:  T R Skopek; F Hutchinson
Journal:  J Mol Biol       Date:  1982-07-25       Impact factor: 5.469

5.  Mutagenesis of lambda phage: 5-bromouracil and hydroxylamine.

Authors:  F Hutchinson; J Stein
Journal:  Mol Gen Genet       Date:  1977-03-28

6.  gamma-Radiolysis of DNA in oxygenated aqueous solutions: alterations at the sugar moiety.

Authors:  M Isildar; M N Schuchmann; D Schulte-Frohlinde; C von Sonntag
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1981-10

7.  Competition between anaerobic covalent linkage of neocarzinostatin chromophore to deoxyribose in DNA and oxygen-dependent strand breakage and base release.

Authors:  L F Povirk; I H Goldberg
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

8.  Deoxyribonucleic acid damage by neocarzinostatin chromophore: strand breaks generated by selective oxidation of C-5' of deoxyribose.

Authors:  L S Kappen; I H Goldberg
Journal:  Biochemistry       Date:  1983-10-11       Impact factor: 3.162

9.  Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides.

Authors:  D Sagher; B Strauss
Journal:  Biochemistry       Date:  1983-09-13       Impact factor: 3.162

10.  Distribution and specificity of mutations induced by neocarzinostatin in the lacI gene of Escherichia coli.

Authors:  P L Foster; E Eisenstadt
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

View more
  8 in total

1.  Selective abstraction of 2H from C-5' of thymidylate in an oligodeoxynucleotide by the radical center at C-6 of the diradical species of neocarzinostatin: chemical evidence for the structure of the activated drug-DNA complex.

Authors:  S M Meschwitz; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Molecular models of neocarzinostatin damage of DNA: analysis of sequence dependence in 5'GAGCG:5'CGCTC.

Authors:  A Galat; I H Goldberg
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

3.  Specificity of ionizing radiation-induced mutagenesis in the lac region of single-stranded phage M13 mp10 DNA.

Authors:  H Ayaki; K Higo; O Yamamoto
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

4.  Probing Enhanced Double-Strand Break Formation at Abasic Sites within Clustered Lesions in Nucleosome Core Particles.

Authors:  Samya Banerjee; Supratim Chakraborty; Marco Paolo Jacinto; Michael D Paul; Morgan V Balster; Marc M Greenberg
Journal:  Biochemistry       Date:  2016-12-22       Impact factor: 3.162

5.  Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal.

Authors:  P C Dedon; J P Plastaras; C A Rouzer; L J Marnett
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

6.  Neocarzinostatin acts as a sensitive probe of DNA microheterogeneity: switching of chemistry from C-1' to C-4' by a G.T mismatch 5' to the site of DNA damage.

Authors:  L S Kappen; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Suppressible base substitution mutations induced by angelicin (isopsoralen) in the Escherichia coli lacI gene: implications for the mechanism of SOS mutagenesis.

Authors:  S S Miller; E Eisenstadt
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

8.  Human DNA polymerase β, but not λ, can bypass a 2-deoxyribonolactone lesion together with proliferating cell nuclear antigen.

Authors:  Emmanuele Crespan; Emanuela Pasi; Shuhei Imoto; Ulrich Hübscher; Marc M Greenberg; Giovanni Maga
Journal:  ACS Chem Biol       Date:  2012-11-07       Impact factor: 5.100

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.